Actively Recruiting
Real-world Secukinumab Outcomes in Canadian HS Patients
Led by Novartis Pharmaceuticals · Updated on 2026-05-13
142
Participants Needed
13
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The HS-RISE study aims to assess real-world HS treatment outcomes and patterns, safety of secukinumab, and to describe the baseline characteristics of patients diagnosed with moderate-to- severe HS who are prescribed secukinumab in Canadian routine clinical practice.
CONDITIONS
Official Title
Real-world Secukinumab Outcomes in Canadian HS Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must give written, signed, and dated informed consent before any information is collected and any study-related activity is performed.
- Adult patients at the time of informed consent signature.
- Patients with the diagnosis of moderate-to-severe HS, as determined by the dermatologist.
- Patients who have been newly prescribed secukinumab as part of routine clinical care according to the approved Canadian PM. The decision to prescribe secukinumab must be made prior to,and independent of, study participation. First treatment with secukinumab must occur no more than 7 days (67 days) prior to Baseline visit.
- Patients who can understand written and spoken Canadian English or French.
You will not qualify if you...
- Any medical or psychological condition in the treating physician's opinion that may prevent the patient from study participation.
- Patients who have any contraindications to treatment with secukinumab, as defined in the Canadian PM.
- Patients who have had any prior exposure to secukinumab (i.e., >7 days prior to the baseline visit).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
Novartis Investigative Site
Calgary, Alberta, Canada, T2J 7E1
Actively Recruiting
2
Novartis Investigative Site
Winnipeg, Manitoba, Canada, R3M 3Z4
Actively Recruiting
3
Novartis Investigative Site
Fredericton, New Brunswick, Canada, E3B 1G9
Actively Recruiting
4
Novartis Investigative Site
Cobourg, Ontario, Canada, K9A 4J9
Actively Recruiting
5
Novartis Investigative Site
Hamilton, Ontario, Canada, L8P4B4
Actively Recruiting
6
Novartis Investigative Site
London, Ontario, Canada, N6H 5L5
Actively Recruiting
7
Novartis Investigative Site
Markham, Ontario, Canada, L3P 1X3
Actively Recruiting
8
Novartis Investigative Site
Mississauga, Ontario, Canada, L4W 0C2
Actively Recruiting
9
Novartis Investigative Site
Richmond Hill, Ontario, Canada, L4C 9M7
Actively Recruiting
10
Novartis Investigative Site
Toronto, Ontario, Canada, M4E 1R7
Actively Recruiting
11
Novartis Investigative Site
Saint-Jérôme, Quebec, Canada, J7Z 7E2
Actively Recruiting
12
Novartis Investigative Site
Sherbrooke, Quebec, Canada, J1L 0H8
Actively Recruiting
13
Novartis Investigative Site
Saskatoon, Saskatchewan, Canada, S7N0N5
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here